Therefore, hypoxia and its downstream mechanical pathways, including MKL1 that is regulated via RhoA/ROCK signaling pathway, can be used as a potential target for treating the early stage of obesity (Fig. 6). The gene discussed is RHOA; the disease is obesity disorder.